The article presents the study on Sterotactic body radiation therapy (SBRT) for improving survival in non-small cell lung cancer (NSCLC). Topics discussed include National Cancer Institutes Surveillance, Epidemiology, and end results database analyzed changes in cancer-specific survival rates and lower survival rates in surgery as compared to SBRT; and SBRT reduction of risk of death rates compared to conventional radiotherapy.